US smoothie brand Smoothie King will launch new Keto Champ smoothie in the country tomorrow 20 August, for carb-conscious consumers. Keto Champ with less than 10-net carbs per 20 oz. serving contains high fat and protein ingredients such as almond butter, grass-fed collagen peptides, MCT oil, cocoa, and almond milk. Containing no artificial colors, flavors […]
US-based specialized polymer materials, services and solutions provider PolyOne has agreed to divest its Performance Products and Solutions (PP&S) business to SK Capital, a private investment firm, for a cash consideration of $775 million. PP&S with sales of approximately $700 million is formulated PVC and polypropylene-based solutions as well as contract manufacturing services provider. With […]
Sorted Group, a UK-based software as a service (SaaS) business, has secured £15 million in a Series B funding, taking the firm’s total funding to over £35 million since its inception in 2010. The investment is expected to help Sorted develop its technology and pave the way for overseas expansion. Alongside Praetura Ventures and NVM […]
ThalesNano, a Hungary-based solution provider for chemists, will introduce MicroCube and the PhotoCube series at the 258th American Chemical Society National Meeting & Exposition, to be held on the 25th August 2019 in San Diego, California, US. MicroCube is a compact reactor for ultrafast heterogeneous chemistry while the PhotoCube is designed for powerful and versatile […]
US-based Horizon Global, a manufacturer of towing and trailering equipment, has agreed to divest its Asia-Pacific (APAC) business segment to Pacific Equity Partners for AUD 340 million in cash. Horizon Global plans to use the cash from the sale of the towing and trailering equipment business in APAC to bring down its debt significantly and […]
Inrebic FDA approval : Celgene’s subsidiary Impact Biomedicines, has bagged approval for its oral kinase inhibitor Inrebic (fedratinib) capsules from the US Food and Drug Administration (FDA) for the treatment of certain types of myelofibrosis, a rare bone marrow cancer. Fedratinib FDA approval is for the treatment of adult patients with intermediate-2 or high-risk primary […]
The post Celgene bags Inrebic FDA approval for myelofibrosis appeared first on PharmaNewsDaily.com.